Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
Supplementary Figure 1.
Repression of miRNAs in MycER tumors. Northern blot analysis of miRNAs in MycERtumors. ‘Expression Ratio’ indicates the level of miRNA expression in the MycON state relative to the MycOFF state. Specific hybridization conditions, as shown in Figs. 1c and 4b, were used for miR-30b and let-7a. tRNALys served as a loading control (representative blot shown).
miR-34a
miR-146a
miR-150
miR-195
miR-15a
miR-26a
miR-22
miR-29a
miR-30b
let-7a
miR-16
Myc
ON
Myc
OFF
0.31
0.37
0.34
0.29
0.51
0.57
0.35
0.46
0.10
0.83
0.41
Expressionratio
tRNALys
miR-34a
miR-30a*
miR-30a
miR-22
miR-30e
miR-30e-3p
miR-30d
miR-146
let-7i
miR-30b
let-7e
miR-29b
miR-30c
miR-26b
miR-29a
miR-29c
let-7b
miR-15a
miR-195
let-7c
miR-26a
let-7g
let-7a
let-7d
miR-150
miR-16
let-7f
Nam
alw
a
Man
ca
Raj
i
Nor
mal
B C
ells
-7 7
Fold expression
a
Myc
Actin
Luc
shR
NA
Myc
shR
NAb
miR-15a
miR-26aLu
c sh
RN
A
miR-22
miR-16
miR-195
miR-146a
miR-30b
U6 snRNA
let-7a
1.35
1.52
1.52
1.50
1.31
1.63
1.34
1.19
FoldinductionM
ycsh
RN
A
c
Supplementary Figure 2.
Myc represses miRNAs in Burkitt’s lymphoma cells. (a) Analysis of previously published miRNA expression profiling data (He et al., Nature, 2005) demonstrates that most Myc-repressed miRNAs are expressed at lower levels in Burkitt’s lymphoma cells compared to normal B cells. (b) Western blot showing Myc knockdown by lentivirally-expressed shRNA in EW36 Burkitt’s lymphoma cells. shRNA directed against luciferase (Luc) served as a negative control. (c) Myc knockdown results in upregulation of miRNAs in EW36 cells. miR-29a was not upregulated by Myc shRNA under these conditions and miR-34a and miR-150 were not expressed at detectable levels in this cell line (not shown).
100%
50%100%
50%100%
50%100%
50%
20 kbC1 N
miR-29b-1/29a
Mouse
Rat
Opossum
Chicken
C2
0
20
40
60
80
100
C1 C2 N
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Myc associates with a conserved region upstream of the miR-29b-1/29a cluster. (a) VISTA analysis of phylogenetic conservation encompassing the miR-29b-1/29a cluster as described in Figure 3a. Amplicons shown in Figure 3b are bolded and underlined. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in Figure 2c.
Supplementary Figure 3.
a
b
Myc associates with a conserved region upstream of the miR-30d/30b cluster. (a) VISTA analysis of phylogenetic conservation encompassing the miR-30d/30b cluster as described in Figure 3a. Amplicons shown in Figure 3b are bolded and underlined. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in
Supplementary Figure 4.
a
b
5 kb
miR-30b
C N
Mouse
Rat
Opossum
Chicken
100%
50%100%
50%100%
50%100%
50%
miR-30d
0
20
40
60
80
100
C N
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Myc associates with a conserved region upstream of miR-34a. (a) VISTA analysis of phylogenetic conservation encompassing miR-34a as described in Figure 3a. Amplicons shown in Figure 3b are bolded and underlined. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in Figure 2c.
Supplementary Figure 5.
a
b
100%GPR157
100%
50%
50%100%
50%100%
50%
miR-34a
10 kbC1 N1
Mouse
Rat
Opossum
Chicken
N3N2C2C3
0
20
40
60
80
100
C1 C2 C3 N1 N2 N3
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Myc associates with a conserved region upstream of miR-146a. (a) VISTA analysis of phylogenetic conservation encompassing miR-146a as described in Figure 3a. Amplicons shown in Figure 3b are bolded and underlined. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in Figure 2c.
Supplementary Figure 6.
a
b
Mouse
Rat
Opossum
Chicken
10 kb
miR-146a
CN
100%
50%100%
50%100%
50%
PTTG1
100%
50%
0
20
40
60
80
100
120
C N
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Myc associates with a conserved region upstream of the miR-195/497 cluster. (a) VISTA analysis of phylogenetic conservation encompassing the miR-195/497 cluster as described in Figure 3a. Amplicons shown in Figure 3b are bolded and underlined. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in Figure 2c.
Supplementary Figure 7.
a
bC2N C4C3C1
1 kb
Mouse
Rat
Opossum
Chicken
100%
50%100%
50%100%
50%100%
50%
MGC49942 BCL6B
miR-195 miR-497
0
20
40
60
80
100
120
C1 C2 C3 C4 N
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Myc does not associate with conserved regions upstream of miR-150. (a) VISTA analysis of phylogenetic conservation encompassing miR-150 as described in Figure 3a. Amplicons shown in Figure 3b are bolded and underlined. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in Figure 2c.
Supplementary Figure 8.
a
b
2 kbC1
Mouse
Rat
Opossum
Chicken
NC3C2
miR-150
RPS11 FCGRT100%
50%100%
50%100%
50%100%
50%
C5 C4 C6
0
20
40
60
80
100
C1 C2 C3 C4 C5 C6 N
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Myc does not associate with conserved regions upstream of the miR-30a/30c-2 cluster. (a) VISTA analysis of phylogenetic conservation encompassing the miR-30a/30c-2 cluster as described in Figure 3a. (b) Real-time PCR analysis of Myc chromatin immunoprecipitates as described in Figure 2c.
Supplementary Figure 9.
a
b
5 kb
Mouse
Rat
Opossum
Frog(X. tropicalis)
miR-30c-2
100%
50%100%
50%100%
50%100%
50%
C6orf155
miR-30a
C2 C4C1 C3 C6C5
0
20
40
60
80
100
C1 C2 C3 C4 C5 C6
Amplicon
Fold
enr
ichm
ent
High Myc (-tet) Low Myc (+tet)
Retroviral miRNA expression levels in Myc3 and 38B9 cells. (a) Numbers below blots represent the expression level of each miRNA relative to the non-transformed B cell line YS-PB11. All quantifications were normalized to to loading control (tRNALys, not shown) and to P493 (low Myc) RNA which was loaded on each gel to allow direct comparison of miRNA levels across blots. (b) Retroviral miR-150 expression was compared to MycOFF tumors since this miRNA was not expressed in YS-PB11 cells (not shown).
Supplementary Figure 10.
miR-22
miR-15a
miR-34a
miR-26a
miR-30b
miR-150
miR-195
0.10 0.73
0.36 6.78
0.01 2.68
0.21 5.06
0.08 1.33
0.11 1.0 0.02 5.93
0.16 3.61
0.10 0.74
0.15 32.7
0.19 5.15
0.17 3.58
0.09 4.45
0.01 3.54
0.15 9.35
1.0
1.0
1.0
1.0
1.0
1.0
miR-160.13 0.60 0.12 0.701.0
Myc3 38B9
MS
CV
-em
pty
MS
CV
-miR
P49
3 (L
ow M
yc)
MS
CV
-em
pty
MS
CV
-miR
P49
3 (L
ow M
yc)
YS-P
B11
P49
3 (L
ow M
yc)
b
a
MycERtumor Myc3 38B9
Myc
ON
Myc
OFF
MS
CV
-em
pty
MS
CV
-miR
P49
3 (L
ow M
yc)
MS
CV
-em
pty
MS
CV
-miR
P49
3 (L
ow M
yc)
miR-26a
miR-22
miR-16
miR-150
miR-195
1.0 0.520.730.90 0.320.660.27 0.420.49
miR-34a
2 126 3624 48 60 72+ -Time after removal of Tet (hr)Tet
0.27
1.0 1.622.082.60 1.081.950.30 1.141.46 0.64
1.0 0.871.251.32 0.761.240.27 0.740.85 0.63
1.0 0.690.850.91 0.610.760.50 0.740.74 0.54
1.0 0.841.141.22 0.351.090.09 0.470.64 0.20
1.0 0.891.070.88 0.640.990.23 0.730.86 0.57
tubulin
Myc
2 126 3624 48 60 72+ -Time after removal of Tet (hr)Tet
b
a
Kinetics of miRNA repression following Myc-induction in P493-6 cells. (a) Western blot demonstrating Myc induction following removal of tetracycline (tet). Leftmost tet (+) or tet (-) lanes represent cells grown with or without tet for 72 hours. (b) Northern blots demonstrating miRNA repression following tet release. Numbers below blots represent expression level of each miRNA relative to tet (+) level, normalized to loading control (tRNALys, not shown). Under these conditions, P493-6 cells do not begin proliferating until 48 hours after tet removal and do not reach maximal growth rates until at least 72 hours after tet removal (our unpublished observations and O’Donnell et al., Mol Cell Bio, 2006).
Supplementary Figure 11.
Supplementary Table 3. Specific wash temperatures for northern blotting.
miR-30 family Specific wash temperature (oC)
miR-30a 44
miR-30b 44
miR-30c 48.5
miR-30d 56
miR-30e 45.5
let-7 family Specific wash temperature (oC)
let-7a 58
let-7b 54
let-7d 54
let-7e 44.5
let-7g 47
let-7i 47.5
miR-98 49.5
miR-99/100 family Specific wash temperature (oC)
miR-99a 48
miR-99b 44
miR-100 48
Supplementary Table 4.
Primer sequences for real-time PCR
miRNA transcription unit Amplicon Forward primer sequence(5'-3')
Reverse primer sequence(5'-3')
Genomic coordinates(Human May 2004 assembly)
miR-15a/miR-16-1 U TGGGCACTGTGCTAAATAAATGA TGAGCAATAAACACGATTAATTCGTAA chr13:49,555,189-49,555,239
miR-15a/miR-16-1 S ATACCGCCTCTTAACCCCCC CATGCGTAAAAATGTCGGGAA chr13:49,554,223-49,554,273
miR-15a/miR-16-1 D AATCGTTAGCTCGAAGCCCC GGGAGGAGTGTTCACGGGT chr13:49,553,109-49,553,159
miR-22 U CTTCTCTCGGCCCAAGACG AACTCTAACCCCCGCTCCC chr17:1,565,542-1,565,592
miR-22 S CTGGCTCTGATTGGCAAGGA TCGTGCAATTCCGCCC chr17:1,566,424-1,566,474
miR-22 D ACCTTAGGGTAGAGGGAGGGCT CATGGCCCATCCCCTAATTT chr17:1,567,079-1,567,129
miR-26a-1 D GGAGAGACTGGGAGCGAGTGT CAAACTCACAACCTCCCGGT chr3:37,878,976-37,879,027
miR-26a-2 U CAACCTTCGAATCCCGAAAG GAGTCCTAGGTCCGCCCAC chr12:56,527,775-56,527,825
miR-26a-2 S CTCCATCTGTGAGCGGCC AAAATAGCAAAGCTCCCGACTG chr12:56,526,949-56,526,999
miR-26b U CAAAATAGTAACGACGAGTGAAAAGAA TGGTCTTTTTCCTCGTTTATGAAGTT chr2:219,089,009-219,089,059
miR-26b S GCTCTTGACGTCCTTGCGAG TTCTCTCCTGTCTGGTGGTCG chr2:219,089,633-219,089,683
miR-26b D AGGTGAGGAAACTGAGGCAGG AGGAAACCCCCGAAGAGTTC chr2:219,090,606-219,090,656
miR-29b-1/miR-29a C1 CACCAACTGAAAACCTGCCA GAATGAACGTTGTGAAATCCCTC chr7:130,055,217-130,055,267
miR-29b-1/miR-29a C2 TGCGCGTGACCAGAAAAGTA GCCTCAGATTGGTTCGCTTG chr7:130,055,889-130,055,939
miR-29b-1/miR-29a N CCTTTCACTCCCAGCCCAAT CCACCATGTGGCTATGACACAG chr7:130,058,638-130,058,688
miR-29b-2/miR-29c C AGGGAGCCAACATGGAGACA CGTTGGAAAGTTGTTTACCTTGC chr1:204,384,665-204,384,715
miR-29b-2/miR-29c N ACTCCAAAGACTGTGTTTCTGCC TTATGGAGCAGGCTGCAGTG chr1:204,365,311-204,365,361
miR-30a/miR-30c-2 C1 AGCAGGTGAAAACAAGCTGAATT TAGTTAATAAAGAAAAAGGCCACAACAT chr6:72,171,129-72,171,179
miR-30a/miR-30c-2 C2 TGAGGTAGAGTGGAAACTGGAGAGA AACTTAAAAAAAAATTCTTCCATCCTTCT chr6:72,175,815-72,175,865
miR-30a/miR-30c-2 C3 AGTGGCATCTTAAAGCAGCACAC TTTTTCCCTTTTGCATTTTGAGA chr6:72,178,504-72,178,554
miR-30a/miR-30c-2 C4 GCACGAATGAATATAAAAACACCAGA AAGTGCTAAAGCTATGGTTGACTGC chr6:72,181,043-72,181,093
miR-30a/miR-30c-2 C5 AGCTGCCTTGGCGTCAGTAA GAAGGATTGAAAATAGCTACTGTGTTCA chr6:72,185,502-72,185,552
miR-30a/miR-30c-2 C6 CCCAATCAGGTGTCGGAAAG CTATTGGCTACACTCCCGGG chr6:72,187,355-72,187,405
miR-30d/miR-30b C GCTCCCTCGCCTTTAGTTTGA GCTCTCCCTCAGACACACTGG chr8:135,913,684-135,913,734
miR-30d/miR-30b N CCCTCGTCATACTATGGCACG ACTTCAAGATCATGCTACTGGGC chr8:135,916,115-135,916,165
miR-30e/miR-30c-1 U TACCATCAGCAGAGGCAGTCA AGTGCATTAGGTAACAAGCGCA chr1:40,825,582-40,825,632
miR-30e/miR-30c-1 S GTCGCCCCTTCCCAATTC TGCGCAGAAGCTGTGCTC chr1:40,826,360-40,826,410
miR-30e/miR-30c-1 D TGGCCTGGCAGGTACTTTG GTGTCCCCCATTCCC chr1:40,827,102-40,827,157
miR-34a C1 GACGGGACAGCGGCATC CCCACCTGGTCCTCTTTCCT chr1:9,176,596-9,176,646
miR-34a C2 GGACTCCCGCAAAATCTCC CTTCTCGGTGACCACGCAG chr1:9,176,406-9,176,456
miR-34a C3 AACATTTTGTTGCTTCTTGGAAATT AATTGTGTAGCCTCCGTAAGGG chr1:9,176,176-9,176,226
miR-34a N1 CCTCCACGGTGGAGATGCT GTTGCTTTTTCCTGTCCCCA chr1:9,192,066-9,192,116
miR-34a N2 AAAGCTGCAGTGTCCAAATTCTC CTGATGTCGGTGACAGTGGG chr1:9,196,246-9,196,296
miR-34a N3 GGCAGGACCCGAAATAAGAAG CACCATTTGGGTGCAGGG chr1:9,196,970-9,197,020
miR-146a C GTGCCGAGGAGGGATCTAGAA CCTGCACGCTAACCCTCTCT chr5:159,827,695-159,827,745
miR-146a N AGATTGCTTCCTGAGAGTAGACAACA GTTAACTGAATTACTGGGTTGGAGC chr5:159,824,970-159,825,020
miR-150 C1 CAGAAACTGCACACCCACTCC GCTGGTTCTCTACTGCCCCC chr19:54,696,108-54,696,158
miR-150 C2 GGGCTGCTGTGTTTACAACAAC CAATCAGGGAGGAAACCGG chr19:54,696,266-54,696,317
miR-150 C3 CAAAGAGCAAGTTTAAAAGACCCC GGTGGAAGGCCTGTCAAGAG chr19:54,696,411-54,696,461
miR-150 C4 ACAGGTTATTTGATAACCCAAGGAGA GGAACCCGCTGACCTAGGA chr19:54,696,814-54,696,864
miR-150 C5 GTACCAGGGTCTGAGCCCAG CATGGCCCTGTCTCCCAAC chr19:54,695,881-54,695,932
miR-150 C6 AGCAGCAGCCTCCCACAG CGTGACTGGAGACCCCAGTT chr19:54,707,714-54,707,764
miR-150 N CTATGGACGCCCTGTGTGC TTAGAGGCTTCAGCAGGCCA chr19:54,700,660-54,700,711
miR-497/miR-195 C1 GGCTTTGGGCGGGAGT CTCTTCTGGGTCCTTGTAGGGAT chr17:6,866,331-6,866,381
miR-497/miR-195 C2 GCAGGACAATGGAAGGAAACC GTACGGAGAGGGCGGATATG chr17:6,866,500-6,866,550
miR-497/miR-195 C3 AGGCCTTCCGACGACTCAG GTTAGGGATATCGAGGTTGGCA chr17:6,866,806-6,866,856
miR-497/miR-195 C4 CCATCTGGAGAGCGAGGGA GGGTGAACGCCTGGGTCT chr17:6,866,981-6,867,031
miR-497/miR-195 N TCCGTCTTTTGCCTGCCTC AAATTGGCATCGGGACAGAG chr17:6,863,862-6,863,912
let-7a-1/let-7f-1/let-7d C TCCGTCGCCATTTTATTTCG CATTCTGCCCACCCGCT chr9:94,008,251-94,008,301
let-7a-1/let-7f-1/let-7d N AGAAGTTTCCGATGAACATATGAAGA AGCACTATGAGCCCTTCTGACAT chr9:94,006,470-94,006,520
let-7g C GTTTTCGCGGAACACCTTAGC ACCGACAGCGTGTTGCG chr3:52,287,358-52,287,408
let-7g N CTGTCGGGAAGTGAACACACC CATGGACCAAAATATGGCATCAT chr3:52,289,423-52,289,473
miR-99a/let-7c/miR-125b-2 C1 TGCACCTATTGTGTCCCTGC ACAGTGGCCAATCGGCA chr21:16,364,637-16,364,687
miR-99a/let-7c/miR-125b-2 C2 CACCCACTTCTTACCAAGAACTCC GCTTTAAGTTGTTCACCCTCAAGTTA chr21:16,488,479-16,488,529
miR-99a/let-7c/miR-125b-2 N AGTTTCACTGCTTCATTCTAAATCCTG CAATGTTTTCCATGTTGGATCAAA chr21:16,487,985-16,488,035
CDKN1A (Fig. 2c) CAGATTTGTGGCTCACTTCGTG CCTGCGTTGGTGCGCT chr6:36,754,186-36,754,236
negative (Fig. 2c) AAACCACCCATCCAGAAGGG CGTGGCAGCACTCGTAAGACT chr1:204,366,822-204,366,872
Primer sequences for characterization of the miR-29b-2/29c primary transcript
Amplicon Forward primer sequence(5'-3')
Reverse primer sequence(5'-3')
5' RACE CGACTGGAGCACGAGGACACTGA GTCAACCCTCTGCATACCCATCTCC
5' nested RACE GGACACTGACATGGACTGAAGGAGTA ATAAAAAGTTTTGGGAGCCCTGAGC
3' RACE AGAGCTGCTGCTGCTGATACTGC GCTGTCAACGATACGCTACGTAACG
3' nested RACE TGGGGACAACAGATTTGCATTGA CGCTACGTAACGGCATGACAGTG
Primer sequences for characterization of the miR-29b-1/29a primary transcript
Amplicon Forward primer sequence(5'-3')
Reverse primer sequence(5'-3')
5' RACE CGACTGGAGCACGAGGACACTGA TCCAAGAACTCACACATTCAGGCAAA
5' nested RACE GGACACTGACATGGACTGAAGGAGTA GTCTGCCGTGACAGTTCAGTAGGAG
3' RACE CTCCTACTGAACTGTCACGGCAGAC GCTGTCAACGATACGCTACGTAACG
3' nested RACE GTATGGATTCATTGCCAGGAGCTG CGCTACGTAACGGCATGACAGTG
Primer sequences for characterization of the miR-146a primary transcript
Amplicon Forward primer sequence(5'-3')
Reverse primer sequence(5'-3')
5' RACE CGACTGGAGCACGAGGACACTGA GCTGAGGATACACATCGGCTTTTC
5' nested RACE GGACACTGACATGGACTGAAGGAGTA CTCCTCGTTGTGCTACTGTCTCCTG
3' RACE TTCAGCTGGGATATCTCTGTCATCG GCTGTCAACGATACGCTACGTAACG
3' nested RACE GGGCTTGAGGACCTGGAGAGAGT CGCTACGTAACGGCATGACAGTG
Primer sequences for miRNA cloning
miRNA transcription unit Forward primer sequence(5'-3')
Reverse primer sequence(5'-3')
miR-15a/miR-16-1 ACCGCTCGAGGGCACAGAATGGACTTCAG ATACCGCTCGAGATGGCTTTTCCCCTTCAGAT
miR-22 ACCGCTCGAGCATGCCCTGCTCAGATCTTT ATACCGCTCGAGCTCTCCAACTTGCCCAAAAC
miR-26a-2 ATACCGCTCGAGCGGCAGGGTGTCTGTCTAGT ATACCGCTCGAGCAGGCTTCCAATGGATCAGT
miR-29b-1/miR-29a ACCGCTCGAGGCATGCTCTCCCATCAATA ATACCGCTCGAGACCACATGCAATTCAGGTCA
miR-30b ATACCGCTCGAGGATCCTGAATGCTGTGCCTGTTCTTT ATACCGCTCGAGATCCCTGCCAGCTAGACAA
miR-34a ATACCGCTCGAGCCTCCTGCATCCTTTCTTT ATACCGCTCGAGCCTGTGCCTTTTTCCTTCC
miR-146a ATACCGCTCGAGAGAGATCCACCCACATCAGC ATACCGCTCGAGCCTGAGACTCTGCCTTCTG
miR-150 ATACCGCTCGAGGAGTGGGTGTGCAGTTTCT ATACCGCTCGAGAGCGCACCAGAGGATATGT
miR-195/miR-497 ATACCGCTCGAGTCCCCTGAGCTGAGTTCCTA ATACCGCTCGAGATTTCCCTCTCAGCTTCGTG
let-7a-1/let-7f-1 ATACCGCTCGAGGAGCGGATTCAGATAACCA ATACCGCTCGAGCAGGACCTGACCTTGGACAT